Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.93584 | 39 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.89696 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.60236 | 26 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.90039 | 41 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.90483 | 41 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.38168 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.07332 | 43 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.87431 | 39 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.02903 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.8797 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.05285 | 45 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.80063 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.91631 | 40 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.9135 | 40 |